Company Filing History:

7 out of 1,177

Takeda Pharmaceutical Company Limited

patents

5 out of 1,858

Takeda Chemical Industries, Inc.

patents

Years Active: 1997-2016

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9475822 - Substituted 2- amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors (2016-10-25),

2. 9212149 - Substituted 2-amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors (2015-12-15),

3. 8183285 - Therapeutic agent for irritable bowel syndrome and methods thereof (2012-05-22),

4. 7915267 - Heterocyclic amide compound and use thereof (2011-03-29),

5. 7256204 - Amine compounds, their production and use (2007-08-14),

6. 7229986 - Melanin-concentrating hormone antagonist (2007-06-12),

7. 7115750 - Melanin concentrating hormone antagonist (2006-10-03),

8. 6613805 - Amine compounds, their production and use (2003-09-02),

9. 6586475 - &bgr;-amyloid protein production/secretion inhibitors (2003-07-01),

10. 6329389 - Amine compounds, their production and use (2001-12-11),

11. 6310107 - Amine compounds, their production and use as amyloid-&bgr; production inhibitors (2001-10-30),

12. 5591849 - Spiro[naphthalene-2(1H),2'-piperidine] and their use (1997-01-07),

Title: Innovations of Jun Terauchi

Introduction

Jun Terauchi is a notable inventor based in Ikeda, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 12 patents to his name, Terauchi's work has the potential to impact various medical treatments.

Latest Patents

One of his latest patents involves substituted 2-amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors. This invention provides a novel amide derivative that exhibits matrix metalloproteinase inhibitory activity, making it useful as a pharmaceutical agent. The compound is represented by a specific formula that includes various structural components, such as nitrogen-containing heterocycles and monocyclic homocycles. The detailed chemical structure and its implications for pharmaceutical applications highlight the innovative nature of Terauchi's work.

Career Highlights

Throughout his career, Jun Terauchi has worked with prominent companies in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Kaneyoshi Kato and Hiroaki Fukumoto. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Jun Terauchi's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his commitment to innovation and improving healthcare solutions. His work continues to pave the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.